Suppr超能文献

伯酰胺作为组织蛋白酶K的选择性抑制剂

Primary amides as selective inhibitors of cathepsin K.

作者信息

Léger Serge, Bayly Christopher I, Black W Cameron, Desmarais Sylvie, Falgueyret Jean-Pierre, Massé Frédéric, Percival M David, Truchon Jean-François

机构信息

Merck Frosst Centre for Therapeutic Research, PO Box 1005, Pointe-Claire-Dorval, Que., Canada H9R 4P8.

出版信息

Bioorg Med Chem Lett. 2007 Aug 1;17(15):4328-32. doi: 10.1016/j.bmcl.2007.05.024. Epub 2007 May 16.

Abstract

The nitrile warhead used in a series of cathepsin K inhibitors can be replaced by a less electrophilic primary amide. The accompanying loss of potency can be partially recovered by introducing a substituent alpha to the amide. The potency gain resulting from this addition is not achieved with the nitrile derivatives due to a different geometry of the cysteine adduct in the enzyme active site. This study led to the identification of the primary amide 2g, which is an inhibitory substrate, with an IC(50) of 10 nM against cathepsin K and excellent selectivity versus the other cathepsins.

摘要

一系列组织蛋白酶K抑制剂中使用的腈弹头可被亲电性较弱的伯酰胺取代。通过在酰胺的α位引入取代基,可部分恢复随之而来的活性损失。由于酶活性位点中半胱氨酸加合物的几何结构不同,腈衍生物无法实现这种添加所带来的活性增强。这项研究导致了伯酰胺2g的鉴定,它是一种抑制性底物,对组织蛋白酶K的IC(50)为10 nM,对其他组织蛋白酶具有优异的选择性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验